US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.

Coming into Year end the IPO market is winding down. This week we have just four IPOs scheduled to raise around $50 million for the week. Cerberus Cyber Sentinel (CISO), Incannex Healthcare (IXHL), Intensity Therapeutics (INTS) and Nuvo Group (NUVO) are expected to debut this week.


Cerberus Cyber Sentinel (CISO)

Cerberus Cyber Sentinel (CISO) based in Scottsdale, Arizona plans to raise $10 million priced at $5 for a $631 million market cap. The company provides a range of cybersecurity consulting and related services, including Secured Managed Services and Compliance Services, among others. Cerberus Cyber Sentinel has delivered explosive growth, but it is unprofitable with negative cash flow. It is listed on the OTC. Managed by Boustead Securities. Proposed Nasdaq symbol CISO.

Incannex Healthcare (IXHL)

Incannex Healthcare is based in Docklands, Australia. The company is an Australian developer of synthetic cannabidiol and psychedelic medicine. The IPO is for 2.6 million shares, priced at $9.38, managed by Roth Capital. Proposed Nasdaq symbol IXHL.

Intensity Therapeutics (INTS)

Intensity Therapeutics is a Phase 1 biotech developing intratumoral injection therapeutics for cancer based in Westport, Conn. The IPO is for 2.1 million shares, priced $6-$8 and managed by A.G.P./Brookline Capital Markets. Proposed Nasdaq symbol INTS.

Nuvo Group (NUVO)

Nuvo Group is developing a remote platform for pregnancy care management. The company is based in Tel Aviv, Israel. The IPO is for 700 thousand shares, priced $14-$16 and managed by Berenberg. Proposed NYSE American symbol NUVO.

 Source: Renaissance Capital SEC Filings

From The TradersCommunity News Desk